Ernexa CEO granted 118K stock options at $4.57

Ernexa Therapeutics Inc. (ERNA) reported that President and CEO Luther Sanjeev received a grant of stock options.

Rhea-AI Filing Summary

Ernexa Therapeutics Inc. (ERNA) reported that President and CEO Luther Sanjeev received a grant of stock options. The award covers 118,848 options to acquire Ernexa common shares at an exercise price of $4.57 per share, expiring on 2036-08-31. Following this grant, Sanjeev holds 118,848 derivative securities of this type.

The options vest over time: one-third of the underlying shares vest on the first anniversary of the grant date, with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter, subject to continued service.

Insider Trade Summary

Grant/Award: 118,848 shares

Grant/Award 1 txn

Insider Luther Sanjeev

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	118,848	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 118,848 contracts (Direct)

Footnotes (1)

1. F1. Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.

Key Figures

Stock options granted: 118,848 options Exercise price: $4.57 per share Expiration date: 2036-08-31 +2 more

5 metrics

Stock options granted 118,848 options Grant of Stock Option (right to buy) on 2026-08-31

Exercise price $4.57 per share Conversion or exercise price for the new stock option award

Expiration date 2036-08-31 Expiration of the granted stock options

Underlying common shares 118,848 shares Common stock underlying the stock option grant

Holdings after transaction 118,848 derivative securities Total stock options of this type held by Luther Sanjeev after the grant

Key Terms

Stock Option (right to buy), exercise price, vesting, substantially equal monthly installments

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion or exercise price: 4.5700"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"shares underlying the stock option will vest on the first anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

substantially equal monthly installments financial

"will vest in 24 substantially equal monthly installments thereafter"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ERNA report for Luther Sanjeev?

Ernexa Therapeutics Inc. reported that President and CEO Luther Sanjeev received a grant of 118,848 stock options to buy Ernexa common stock, with an exercise price of $4.57 per share and an expiration date of 2036-08-31.

What is the exercise price of the new stock options granted at ERNA?

The stock options granted to Luther Sanjeev by Ernexa Therapeutics Inc. have an exercise price of $4.57 per share, allowing him to purchase Ernexa common stock at that price if the options are exercised before expiration.

How many ERNA stock options were granted to Luther Sanjeev?

Luther Sanjeev was granted 118,848 stock options for Ernexa Therapeutics Inc. common stock. These options, if vested and exercised, would entitle him to purchase up to 118,848 shares at the specified exercise price.

When do the newly granted ERNA stock options expire?

The stock options granted to Luther Sanjeev by Ernexa Therapeutics Inc. expire on 2036-08-31. Any options not exercised by that date will terminate according to the option terms.

What is the vesting schedule for Luther Sanjeev’s ERNA stock options?

Subject to continued service, one-third of the shares underlying the Ernexa stock option vest on the first anniversary of the grant date. The remaining shares vest in 24 substantially equal monthly installments thereafter.

How many ERNA derivative securities does Luther Sanjeev hold after this grant?

After this grant, Luther Sanjeev holds 118,848 derivative securities of this stock option type related to Ernexa Therapeutics Inc. common stock, as reported in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 09:47 PM EDT Accepted by SEC EDGAR 09/01/2026 - 09:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luther Sanjeev

(Last) (First) (Middle)

C/O ERNEXA THERAPEUTICS INC.

1035 CAMBRIDGE STREET, STE. 18A

(Street)

CAMBRIDGE MASSACHUSETTS 02141

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ernexa Therapeutics Inc. [ ERNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$4.57	08/31/2026		A		118,848		(1)	08/31/2036	Common Stock	118,848	$0	118,848	D

Explanation of Responses:

1. Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.

	/s/ Sanjeev Luther	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)